Besifloxacin

ATC S01AE08 · 5 markets · 8 records

Besifloxacin 5 markets · 8 records Forms
Filters

US 4 records · 1 shown of 1 Source openFDA NDC Directory · Data as of 2026-10-23

  • 6 mg per mL / per unit basis not statedliquidBesivance

CA 1 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

  • 0.6 % per mL / per unit basis not statedliquidBesivance

AU 1 records · 1 shown of 1 Source TGA · Data as of 2026-10-28 · includes records with unknown status (not proof of sale)

  • 6.06 mg/mL per mL / per unit basis not statedliquidBESIVANCE besifloxacin 0.6% w/v suspension eye drops bottle unknown

TW 1 records · 0 shown of 0 Source 衛生福利部食品藥物管理署(TFDA)全部藥品許可證資料集 · Data as of 2026-10-22 · some records have no stated strength

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Besivance (besifloxacin ophthalmic suspension, 0.6%) ×1博倫眼用懸液劑 0.6% ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.